(Q37163734)

English

High-dose imatinib in newly diagnosed chronic-phase chronic myeloid leukemia: high rates of rapid cytogenetic and molecular responses

scientific article published on 31 August 2009

Statements

High-dose imatinib in newly diagnosed chronic-phase chronic myeloid leukemia: high rates of rapid cytogenetic and molecular responses (English)
Stuart L Goldberg
Bayard L Powell
Karen McDougall
Rationale and Insight for Gleevec High-Dose Therapy (RIGHT) Trial Study Group

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit